Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro

被引:19
作者
Zarubaev, VV
Slita, AV
Krivitskaya, VZ
Sirotkin, AK
Kovalenko, AL
Chatterjee, NK
机构
[1] New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, New York, NY USA
[2] Influenza Res Inst, Dept Chemotherapy, St Petersburg 197376, Russia
[3] STPC Polisan, St Petersburg, Russia
基金
美国国家卫生研究院;
关键词
acridone; adenovirus; antiviral; electron microscopy;
D O I
10.1016/S0166-3542(02)00193-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenoviruses represent a broad group of human pathogens that currently have no specific and safe drugs for treatment. We demonstrated direct (non IFN-mediated) antiviral activity of cycloferon (10-carboxymethyl-9-acridanone, CMA), a potent interferon inducer, against adenovirus type 6 (AM) in Hep-2 cells. Virus production and details of morphogenesis were studied by ELISA with antibodies to the Ad6 hexon protein, and transmission electron microscopy, respectively. Immunoenzyme assay revealed that CMA does not inhibit viral protein synthesis but instead strongly reduces the ability of the virus to generate infectious progeny virus in a dose dependent manner. Ultrastructural study shows that CMA alters the structure of intranuclear virus-specific inclusions. We suggest that CMA suppresses the late stages of viral cycle in the infected cell. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:131 / 137
页数:7
相关论文
共 47 条
  • [1] 1,3-dihydroxyacridone derivatives as inhibitors of herpes virus replication
    Akanitapichat, P
    Lowden, CT
    Bastow, KF
    [J]. ANTIVIRAL RESEARCH, 2000, 45 (02) : 123 - 134
  • [2] The antiviral agent 5-chloro-1,3-dihydroxyacridone interferes with assembly and maturation of herpes simplex virus
    Akanitapichat, P
    Bastow, KF
    [J]. ANTIVIRAL RESEARCH, 2002, 53 (02) : 113 - 126
  • [3] Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient
    Arav-Boger, R
    Echavarria, M
    Forman, M
    Charache, P
    Persaud, D
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (11) : 1097 - 1100
  • [4] Bastow K F, 1994, Bioorg Med Chem, V2, P1403, DOI 10.1016/S0968-0896(00)82092-1
  • [5] Bordigoni Pierre, 2001, Clinical Infectious Diseases, V32, P1290, DOI 10.1086/319984
  • [6] ASSEMBLY OF ADENOVIRUS-SPECIFIC NUCLEAR INCLUSIONS IN LYTICALLY INFECTED HELA-CELLS - AN ULTRASTRUCTURAL AND CYTOCHEMICAL STUDY
    CHALY, N
    CHEN, X
    [J]. BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1993, 71 (9-10): : 475 - 487
  • [7] Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir
    Chen, FE
    Liang, RHS
    Lo, JY
    Yuen, KY
    Chan, TK
    Peiris, M
    [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 997 - 999
  • [8] ADENOVIRUS INFECTION ELEVATES LEVELS OF CELLULAR TOPOISOMERASE-I
    CHOW, KC
    PEARSON, GD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) : 2247 - 2251
  • [9] D'Halluin J C, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P47
  • [10] Inhibition of herpes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate
    Das, A
    Trousdale, MD
    Ren, SJ
    Lien, EJ
    [J]. ANTIVIRAL RESEARCH, 1999, 44 (03) : 201 - 208